. 2023 Jun 27;23:327. doi: 10.1186/s12872-023-03353-1

Table 4.

Comparison of general information between the two groups before and after treatment

Variables	/Matched group (n = 198)	SGLT2-inhibitor group (n = 135)	t/χ²	P-value
Abnormal blood glucose	12 (6.06%)	1 (0.74%)	6.06	0.014
ALT difference (U/L)	3.37 ± 17.32	4.21 ± 9.35	0.58	0.565
UA difference (µmmol/L)	-4.24 ± 57.43	-10.59 ± 27.35	-1.20	0.233
eGER difference (ml/min)	-2.54 ± 7.40	-1.61 ± 4.93	1.37	0.173
Hypotension, hypoglycemia, and urinary tract infection	0(0%)	1(0.74%)		0.405^a

Data are represented as n (%) or x ± s. Note. a: Fisher’s Exact Test